<?xml version='1.0' encoding='utf-8'?>
<Document xmlns="urn:iso:std:iso:20022:tech:xsd:pacs.002.001.10"><FIToFIPmtStsRpt><GrpHdr><MsgId>PACS002-ACSC-3de6e38b</MsgId><CreDtTm>2025-09-27T16:00:00+00:00Z</CreDtTm></GrpHdr><OrgnlGrpInfAndSts><OrgnlMsgId>PAIN-2025-09-27-Northern_Pharma_SRL-ef78f437</OrgnlMsgId><OrgnlMsgNmId>pain.001.001.09</OrgnlMsgNmId><GrpSts>PART</GrpSts></OrgnlGrpInfAndSts><OrgnlPmtInfAndSts><OrgnlPmtInfId>PMTINF-2025-09-27-58ffca</OrgnlPmtInfId><TxInfAndSts><StsId>STS-f8244492</StsId><OrgnlInstrId>INST-20250927-00992</OrgnlInstrId><OrgnlEndToEndId>E2E-20250927-00992</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-27T16:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="JPY">8580.36</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-7554c4e5</StsId><OrgnlInstrId>INST-20250927-01042</OrgnlInstrId><OrgnlEndToEndId>E2E-20250927-01042</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-27T16:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="SEK">220031.78</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-74cda50e</StsId><OrgnlInstrId>INST-20250927-01129</OrgnlInstrId><OrgnlEndToEndId>E2E-20250927-01129</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-27T16:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="AUD">7435.10</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-55ac102d</StsId><OrgnlInstrId>INST-20250927-01143</OrgnlInstrId><OrgnlEndToEndId>E2E-20250927-01143</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-27T16:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="JPY">136796.04</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-23d6fc59</StsId><OrgnlInstrId>INST-20250927-01149</OrgnlInstrId><OrgnlEndToEndId>E2E-20250927-01149</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-27T16:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="CHF">6402.91</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts></OrgnlPmtInfAndSts></FIToFIPmtStsRpt></Document>